$0.00312
-0.0633-95.31%
Last update: Nov 6, 10:17 AM

PETROS PHARM INC by Petros Pharmaceuticals, Inc. (PTPI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-0.30 | $-0.03 | $0.44 | $-0.03 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 13, 2024 | $-13.25 | $-7.25 | -82.8 % |
| Q2 | Aug 14, 2024 | $-9.25 | $-19.25 | 51.9 % |
| Q1 | May 15, 2024 | $-42.25 | $-36.00 | -17.4 % |
| Q4 | Apr 1, 2024 | $-54.25 | $-27.75 | -95.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 13, 2024 | $1.58M | $1.34M | 17.6 % |
| Q2 | Aug 14, 2024 | $1.42M | $1.40M | 1.50 % |
| Q1 | May 15, 2024 | $1.39M | $1.45M | -4.21 % |
| Q4 | Apr 1, 2024 | $364.25K | $1.55M | -76.5 % |